Corteva (NYSE:CTVA) Given New $96.00 Price Target at Mizuho

Corteva (NYSE:CTVA) had its target price increased by equities researchers at Mizuho from $94.00 to $96.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s price objective suggests a potential upside of 14.09% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Argus raised their target price on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. CICC Research lifted their price objective on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Royal Bank Of Canada raised their price objective on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. The Goldman Sachs Group upped their price target on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Finally, Jefferies Financial Group increased their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.90.

Corteva Stock Performance

Shares of Corteva stock opened at $84.14 on Thursday. The stock has a market cap of $56.28 billion, a price-to-earnings ratio of 48.98, a P/E/G ratio of 2.59 and a beta of 0.55. Corteva has a twelve month low of $60.53 and a twelve month high of $85.95. The company’s fifty day moving average is $79.57 and its 200 day moving average is $76.66. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts forecast that Corteva will post 3.72 EPS for the current year.

Hedge Funds Weigh In On Corteva

A number of institutional investors and hedge funds have recently made changes to their positions in the business. William B. Walkup & Associates Inc. raised its position in Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after purchasing an additional 126 shares during the period. Wilkerson Advisory Group LLC lifted its position in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after buying an additional 133 shares during the last quarter. AdvisorNet Financial Inc increased its position in Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after acquiring an additional 135 shares during the last quarter. First Horizon Corp increased its position in Corteva by 9.2% during the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares during the last quarter. Finally, Aviance Capital Partners LLC raised its stake in shares of Corteva by 1.3% in the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after acquiring an additional 137 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.